Emerging concepts of apolipoprotein D with possible implications for breast cancer

Cellular Oncology

Volumn 29, Issue 3, 2007, Pages 195-209

  Søiland, Håvard ^a,b   Søreide, Kjetil ^a,b   Janssen, Emiel A M ^a,b   Körner, Hartwig ^a,b   Baak, Jan P A ^a,b,c   Søreide, Jon Arne ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Apolipoprotein D; Biology; Breast cancer; Molecular; Predictive factor; Prognosis; Review; Tamoxifen

Indexed keywords

ANDROGEN RECEPTOR; APOLIPOPROTEIN D; ARACHIDONIC ACID; ESTROGEN RECEPTOR; GLUCOCORTICOID; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE RECEPTOR; PROSTAGLANDIN; RETINOL; TAMOXIFEN; VITAMIN D;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER STAGING; CELL MOTILITY; ENZYME ACTIVITY; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW;

ANIMALS; APOLIPOPROTEINS D; BREAST NEOPLASMS; CELL AGING; HUMANS; MAP KINASE SIGNALING SYSTEM; PROSTAGLANDINS; RECEPTORS, CELL SURFACE;

EID: 34249805099     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts and P. Walter, Cell junctions, cell adhesions, and the extracellular matrix, in: The Molecular Biology of the Cell, 4th edn, Garland Science, 2002, pp. 1111-1112.
2. M. Ayrault Jarrier, G. Levy and J. Polonovski, Study of Human serum alpha-lipoproteins by immunoelectrophoresis, Bull. Soc. Chim. Biol. (Paris) 45 (1963), 703-713.
3. J.P. Baak, P.J. van Diest, F.J. Voorhorst, E. van der Wall, L.V. Beex, J.B. Vermorken and E.A. Janssen, Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years, J. Clin. Oncol. 23 (2005), 5993-6001.
4. M. Balbin, J.M. Freije, A. Fueyo, L.M. Sanchez and C. Lopez-Otin, Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease, Biochem. J. 271 (1990), 803-807.
5. I. Ben-Porath and R.A. Weinberg, The signals and pathways activating cellular senescence, Int. J. Biochem. Cell. Biol. 37 (2005), 961-976.
6. Y. Blais, K. Sugimoto, M.C. Carriere, D.E. Haagensen, F. Labrie and J. Simard, Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cells, Int. J. Cancer 62 (1995), 732-737.
7. Y. Blais, K.Sugimoto, M.C. Carriere, D.E. Haagensen, F. Labrie and J. Simard, Potent stimulatory effect of interleukin-1 alpha on apolipoprotein D and gross cystic disease fluid protein-15 expression in human breast-cancer cells, Int. J. Cancer 59 (1994), 400-407.
8. J.K. Boyles, L.M. Notterpek, M.R. Wardell and S.C. Rall Jr., Indentification, characterisation and tissue distribution of apolipoprotein D in rat, J. Lipid. Res. 31 (1990), 2243-2256.
9. T. Bratt, Lipocalins and cancer, Biochim. Biophys. Acta 1482 (2000), 318-326.
10. A.M. Brodie, Q. Lu, B.J. Long, A. Fulton, T. Chen, N. Macpherson, P.C. DeJong, M.A. Blankenstein, J.W. Nortier and P.H. Slee, Aromatase and COX-2 expression in human breast cancers, J. Steroid. Biochem. Mol. Biol. 79 (2001), 41-47.
11. A. Brunet, D. Roux, P. Lenormand, S. Dowd, S. Keyse and J. Pouyssegur, Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry, EMBO J. 18 (1999), 664-674.
12. J. Campisi, Suppressing cancer: the importance of being senescent, Science 309 (2005), 886-887.
13. J. Campisi, Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors, Cell 120 (2005), 513-522.
14. D. Chalbos and F. Galtier, Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription, J. Biol. Chem. 269 (1994), 23007-23012.
15. H.M. Costa-Junior, F.C. Hamaty, R. da Silva Farias, M. Einicker-Lamas, M.H. da Silva and P.M. Persechini, Apoptosis-inducing factor of a cytotoxic T cell line: involvement of a secretory phospholipase A(2), Cell Tissue Res. 324 (2006), 255-266.
16. Y. de Launoit, R. Veilleux, M. Dufour, J. Simard and F. Labrie, Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells, Cancer Res. 51 (1991), 5165-5170.
17. P.P. Desai, C.H. Bunker, F.A. Ukoli and M.I. Kamboh, Genetic variation in the apolipoprotein D gene among African blacks and its significance in lipid metabolism, Atherosclerosis 163 (2002), 329-338.
18. I. Diez-Itza, F. Vizoso, A.M. Merino, L.M. Sanchez, J. Tolivia, J. Fernandez, A. Ruibal and C. Lopez-Oti, Expression and prognostic significance of apolipoprotein D in breast cancer, Am. J. Pathol. 144 (1994), 310-320.
19. S. Do Carmo, D. Seguin, R. Milne and E. Rassart, Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter, J. Biol. Chem. 277 (2002), 5514-5523.
20. D. Drayna, C. Fielding, J. McLean, B. Baer, G. Castro, E. Chen, L. Comstock, L. Henzel, W. Kohr and L. Rhee, Cloning and expression of human apolipoprotein D cDNA, J. Biol. Chem. 261 (1986), 16535-16539.
21. D.T. Drayna, J.W. McLean, K.L. Wion, J.M. Trent, H.A. Drabkin and R.M. Lawn, Human apolipoprotein D gene: gene sequence, chromosome localization, and homology to the alpha 2u-globulin superfamily, DNA 6 (1987), 199-204.
22. R.M. Evans, The nuclear receptor superfamily: a rosetta stone for physiology, Mol. Endocrinol. 19 (2005), 1429-1438.
23. D.R. Flower, Beyond the superfamily: the lipocalin receptors, Biochem. Biophys. Acta 1482 (2000), 327-336.
24. D.R. Flower, The lipocalin protein family: a role in cell regulation, FEBS Lett. 354 (1994), 7-11.
25. D.R. Flower, The lipocalin protein family: structural and sequence overview, Biochem. Biophys. Acta 1482 (2000), 9-24.
26. T.T. Fung, E.B. Rimm, D. Spiegelman, N. Rifai, G.H. Tofler, H.C. Willett and F.B. Hu, Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk, Am. J. Clin. Nutr. 73 (2001), 61-67.
27. W. Goessling and S.D. Zucker, Role of apolipoprotein D in the transport of bilirubin in plasma, Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000), G356-365.
28. J.D. Graham and C.L. Clarke, Physiological action of progesterone in target tissues, Endocr. Rev. 18 (1997), 502-519.
29. J.D. Graham, C. Yeates, R.L. Balleine, S.S. Harvey, J.S. Milliken, A.M. Bilous and C.L. Clarke, Characterization of progesterone receptor A and B expression in human breast cancer, Cancer. Res. 55 (1995), 5063-5068.
30. J.P. Guastalla, T. Bachelot and I. Ray-Coquard, Cyclooxygenase 2 and breast cancer. From biological concepts to therapeutic trials, Bull. Cancer 91 (2004), S99-108.
31. D.E. Haagensen Jr., G. Mazoujian, W.D. Holder Jr., S.J. Kister, and S.A. Wells Jr., Evaluation of a breast cyst fluid protein detectable in the plasma of breast carcinoma patients, Ann. Surg. 185 (1977), 279-285.
32. D.E. Haagensen Jr., G. Mazoujian, W.G. Dilley, C.E. Pedersen, S.J. Kister and S.A. Wells Jr., Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein, J. Natl. Cancer Inst. 62 (1979), 239-247.
33. D.E. Haagensen, P. Stewart, W.G. Dilley and S.A. Wells, Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture - modulation by steroid hormones, Breast Cancer Res. Treat. 23 (1992), 77-86.
34. R.E. Hall, J.O. Aspinall, D.J. Horsfall, S.N. Birrell, J.M. Bentel, R.L. Sutherland and W.D. Tilley, Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer, Br. J. Cancer 74 (1996), 1175-1180.
35. C. Harding, O. Osundeko, L. Tetlow, E.B. Faragher, A. Howell and N.J. Bundred, Hormonally-regulated proteins in breast secretions are markers of target organ sensitivity, Br. J. Cancer 82 (2000), 354-360.
36. C.A. Heinlein and C. Chang, The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions, Mol. Endocrinol. 16 (2002), 2181-2187.
37. L. Huang and C. Li, Leptin: a multifunctional hormone, Cell. Res. 10 (2000), 81-92.
38. C.A. Iacobuzio-Donahue, B. Ryu, R.H. Hruban and S.E. Kern, Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion, Am. J. Pathol. 160 (2002), 91-99.
39. M.I. Kamboh, J.J. Albers, P.P. Majumder and R.E. Ferrell, Genetic studies of human apolipoproteins. IX. Apolipoprotein D polymorphism and its relation to serum lipoprotein lipid levels, Am. J. Hum. Genet. 45 (1989), 147-154.
40. M.K. Kang, A. Kameta, K.H. Shin, M.A. Baluda, H.R. Kim and N.H. Park, Senescence-associated genes in normal human oral keratinocytes, Exp. Cell. Res. 287 (2003), 272-281.
41. V.N. Kristensen, T. Sørlie, J. Geisler, N. Yoshimura, O.C. Linegjærde, I. Glad, A. Frigessi, N. Harada, P.E. Lønning and A.L. Børresen-Dale, Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer, J. Steroid. Biochem. Mol. Biol. 95 (2005), 105-111.
42. J. Lambert, P.R. Provost, Y.L. Marcel and E. Rassart, Structure of the human apolipoprotein D gene promoter region, Biochim. Biophys. Acta 1172 (1993), 190-192.
43. M.L. Lamelas, J. Vazquez, M.I. Enguita, J.C. Rodriguez, L.O. Gonzalez, A.M. Merino and F. Vizoso, Apolipoprotein D expression in metastasic lymph nodes of breast cancer, Int. J. Surg. Investig. 2 (2000), 285-293.
44. W.E. Lands, Stories about acyl chains, Biochim. Biophys. Acta 1483 (2000), 1-14.
45. C.A. Lange, J.K. Richer, T. Shen and K.B. Horwitz, Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways, J. Biol. Chem. 273 (1998), 31308-31316.
46. K. Laud, I. Gourdou, L. Pessemesse, J.P. Peyrat and J. Djiane, Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line, Mol. Cell. Endocrinol. 188 (2002), 219-226.
47. O.A. Lea, T. Thorsen and S. Kvinnsland, Extracellular proteins in breast tumor cytosol, Anticancer Res. 7 (1987), 113-117.
48. O.A. Lea, Binding properties of progesterone-binding Cyst protein, PBCP, Steroids 52 (1988), 337-338.
49. O.A. Lea, S. Kvinnsland and T. Thorsen, Progesterone-binding cyst protein in human breast tumor cytosol, Cancer Res. 47 (1987), 6189-6192.
50. W.C. Leung, A. Lawrie A, S. Demaries, H. Massaeli, A. Burry, S. Yablonsky, J.M. Sarjeant, E. Fera, E. Rassart and J.G. Pickering, Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration, Circ. Res. 95 (2004), 179-186.
51. E.R. Levin, Cell localization, physiology, and nongenomic actions of estrogen receptors, J. Appl. Physiol. 91 (2001), 1860-1867.
52. Z. Liu, G.Q. Chang and S.F. Leibowitz, Apolipoprotein D interacts with the long-form leptin receptor: a hypothalamic function in the control of energy homeostasis, FASEB J. 15 (2001), 1329-1331.
53. Y.S. Lopez-Boado, J. Tolivia and C. Lopez-Otin, Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentiation in human breast cancer cells, J. Biol. Chem. 269 (1994), 26871-26878.
54. Y.S. Lopez-Boado, M. Klaus, M.I. Dawson and C. Lopez-Otin, Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARalpha-dependent signaling pathway, J. Biol. Chem. 271 (1996), 32105-32111.
55. Y.S. Lopez-Boado, X.S. Puente, S. Alvarez, J. Tolivia, L. Binderup L and C. Lopez-Otin, Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression, Cancer Res. 57 (1997), 4091-4097.
56. R. Losel and M. Wehling, Nongenomic actions of steroid hormones, Nat. Rev. Mol. Cell. Biol. 4 (2003), 46-56.
57. C.C. Lynch, A. Hikosaka, H.B. Acuff, M.D. Martin, N. Kawai, R.K. Singh, T.C. Vargo-Gogola, J.L. Begtrup, T.E. Peterson and B. Fingleton, MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL, Cancer Cell 7 (2005), 485-496.
58. M. Matsuyama, R. Yoshimura, M. Mitsuhashi, K. Tsuchida, Y. Takemoto, Y. Kawahito, H. Sano and T. Nakatani, 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway, Oncol. Rep. 14 (2005), 73-79.
59. K.S. McCarty Jr., E. Szabo, J.L. Flowers, E.B. Cox, G.S. Leight, L. Miller, J. Konrath, J.T. Soper, D.A. Budwit and W.T. Creasman, Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors, Cancer Res. 46 (1986), 4244-4248.
60. E.M. McGowan and C.L. Clarke, Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells, Mol. Endocrinol. 13 (1999), 1657-1671.
61. J.H. Morais Cabral, G.L. Atkins, L.M. Sanchez, Y.S. Lopez-Boado, C. Lopez-Otin and L. Sawyer, Arachidonic acid binds to apolipoprotein D: implications for the protein's function, FEBS Lett. 366 (1995), 53-56.
62. P.A. Mote, S. Bartow, N. Tran and C.L. Clarke, Loss of coordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis, Breast Cancer Res. Treat. 72 (2002), 163-172.
63. H. Mueller, N. Flury, S. Eppenberger-Castori, W. Kueng, F. David and U. Eppenberger, Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients, Int. J. Cancer 89 (2000), 384-388.
64. K. Ogawa, T. Utsunomiya, K. Mimori, K. Yamashita, M. Okamoto, F. Tanaka H. Inoue, Y. Ikeda, M. Saku and S. Murayama, Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application, Int. J. Oncol. 27 (2005), 417-426.
65. Online Database, The Online Mendelian Inheritance in Man (OMIM) gene map: www.ncbi.nlm.nih.gov/mapview/map_search.cgi?taxid=9606&query= APOD, John Hopkins University, 1996-2005; sited July 1, 2006.
66. Online Database, RSCB Protein Data Bank: www.modbase. compbio.ucsf.edu, Protein ID: Q6IBG6. Sited July 1, 2006.
67. C.K. Osborne and R. Schiff, Estrogen-receptor biology: continuing progress and therapeutic implications, J. Clin. Oncol. 23 (2005), 1616-1622.
68. C.K. Osborne, J. Shou, S. Massarweh and R. Schiff, Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer, Clin. Cancer Res. 11 (2005), 865s-870s.
69. L. Pal, B. Dasgupta and P. Chakrabarti, 3(10)-helix adjoining alpha-helix and beta-strand-sequence and structural features and their conservation, Biopolymers 78 (2005), 147-162.
70. S. Parrinello, J.P. Coppe, A. Krtolica and J. Campisi, Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation, J. Cell. Sci. 118 (2005), 485-496.
71. R.C. Patel, D. Lange, W.J. McConathy, Y.C. Patel and S.C. Patel, Probing the structure of the ligand binding cavity of lipocalins by fluorescence spectroscopy, Protein Eng. 10 (1997), 621-625.
72. W.H. Pearlman, J.L. Gueriguian and M.E. Sawyer, A specific progesterone-binding component of human breast cyst fluid, J. Biol. Chem. 248 (1973), 5736-5741.
73. R. Perez, X. Matabosch, A. Llebaria, M.A.Balboa and J. Balsinde, Blockade of arachidonic acid incorporation into phospholipids induces apoptosis in U937 promonocytic cells, J. Lipid. Res. 47 (2006), 484-491.
74. P.R. Provost, Y.L. Marcel, R.W. Milne, P.K. Weech and E. Rassart, Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures, FEBS Lett. 290 (1991), 139-141.
75. E. Rassart, A. Bedirian, S. Do Carmo, O. Guinard, J. Sirois, L. Terrisse and R. Milne, Apolipoprotein D, Biochim. Biophys. Acta 1482 (2000), 185-198.
76. F. Ricci, S.E. Kern, R.H. Hruban and C.A. Iacobuzio-Donahue, Stromal responses to carcinomas of the pancreas: Juxtatumoral gene expression conforms to the infiltrating pattern and not the biologic subtype, Cancer Biol. Ther. 4 (2005), 302-307.
77. J.K. Richer, C.A. Lange, N.G. Manning, G. Owen, R. Powell and K.B. Horwitz, Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity, J. Biol. Chem. 273 (1998), 31317-31326.
78. M. Romano and J. Claria, Cyclooxygenase-2 and 5-lipoxy-genase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy, FASEB J. 17 (2003), 1986-1995.
79. D.P. Rose, E.M. Gilhooly and D.W. Nixon, Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review), Int. J. Oncol. 21 (2002), 1285-1292.
80. L. Ryden, B. Linderholm, N.H. Nielsen, S. Emdin, P.E. Jonsson and G. Landberg, Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer, Breast Cancer Res. Treat. 82 (2003), 147-154.
81. J.M. Sarjeant, A. Lawrie, C. Kinnear, S. Yablonsky, W. Leung, H. Massaeli, W. Prichett, J.P. Neinot, E. Rassart and M. Rabinovitch, Apolipoprotein D inhibits platelet-derivied growht factor-BB-induced vascular smooth muscle cell profilated by preventing translocation of phosphorylated extracellular signal related kinase 1/2 to the nucleus, Arterioscler. Thromb. Vasc. Biol. 23 (2003), 2172-2177.
82. F. Satoh, S. Umemura and R.Y. Osamura, Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue, Breast Cancer 7 (2000), 49-55.
83. D.C. Sgroi, S. Teng, G. Robinson, R. Le Vangie, J.R. Hudson Jr. and A.G. Elkahloun, In vivo gene expression profile analysis of human breast cancer progression, Cancer Res. 59 (1999), 5656-5661.
84. J.S. Silva, C.E. Cox, S.A. Wells Jr., D. Paull, W.G. Dilley, K.S. McCarty Sr., B.F. Fetter, L.C. Glaubitz and K.S. McCarty Jr., Biochemical correlates of morphologic differentiation in human breast cancer, Surgery 92 (1982), 443-449.
85. J. Simard, S. Dauvois, D.E. Haagensen, C. Levesque, Y. Merand and F. Labrie, Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer, Endocrinology 126 (1990), 3223-3231.
86. J. Simard, R. Veilleux, Y. de Launoit, D.E. Haagensen and F. Labrie, Stimulation of apolipoprotein D secretion by steroids coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells, Cancer Res. 51 (1991), 4336-4341.
87. J. Simard, Y. de Launoit, D.E. Haagensen and F. Labrie, Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells, Endocrinology 130 (1992), 1115-1121.
88. B. Singh, J.A. Berry, A. Shoher, V. Ramakrishnan and A. Lucci, COX-2 overexpression increases motility and invasion of breast cancer cells, Int. J. Oncol. 26 (2005), 1393-1399.
89. V.S. Sivaraman, H. Wang, G.J. Nuovo and C.C. Malbon, Hyperexpression of mitogen-activated protein kinase in human breast cancer, J. Clin. Invest. 99 (1997), 1478-1483.
90. K.M. Smith, R.M. Lawn and J.N. Wilcox, Cellular localization of apolipoprotein D and lecithin:cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization, J. Lipid. Res. 31 (1990), 995-1004.
91. R.X. Song, R.A. McPherson, L. Adam, Y. Bao, M. Shupnik, R. Kuma and R.J. Santen, Linkage of rapid estrogen action to MAPK activation by ER alpha-Shc association and Shc pathway activation, Mol. Endocrinol. 16 (2002), 116-127.
92. J.A. Søreide, O.A. Lea and S. Kvinnsland, Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor?, Breast Cancer Res. Treat. 9 (1987), 123-128.
93. J.A. Søreide, O.A. Lea, O. Anda, A. Skarstein, J.E. Varhaug and S. Kvinnsland, Progesterone-binding cyst protein (PBCP) in operable breast cancer: correlations with prognostic factors and predictive value for effect of adjuvant tamoxifen treatment, Anticancer Res. 11 (1991), 601-605.
94. J.A. Søreide, O.A. Lea and S. Kvinnsland, Progesterone-binding cyst protein (PBCP = GCDFP-24) and steroid hormone receptors as markers of differentiation in breast cancer. Inverse relation of distribution in normal and malignant tissue of the same breast, Anticancer Res. 11 (1991), 1323-1326.
95. L. Speroff, R.H. Glass and N.G. Kase, Hormone biosynthesis, metabolism, and mechanisms of action, in: Clinical Gynaecologic Endocrinology and Infertility, 5th edn, C. Mitchell, ed., William & Wilkins, Baltimore, 1994, p. 53.
96. K. Sugimoto, J. Simard, D.E. Haagensen and F. Labrie, Inverse relationships between cell proliferation and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cells, J. Steroid Biochem. Mol. Biol. 51 (1994), 167-174.
97. S. Sundaram and J. Ghosh, Expression of 5-oxoETE receptor in prostate cancer cells: Critical role in survival, Biochem. Biophys. Res. Commun. 6 (2006), 93-98.
98. T. Suzuki, Y. Miki, Y. Nakamura, T. Moriya, K. Ito, N. Ohuch and H. Sasano, Sex steroid-producing enzymes in human breast cancer, Endocr. Relat. Cancer 12 (2005), 701-720.
99. E.A. Thomas, D.L. Copolov and J.G. Sutcliffe, From pharmacotherapy to pathophysiology: emerging mechanisms of apolipoprotein D in psychiatric disorders, Curr. Mol. Med. 3 (2003), 408-418.
100. E.A. Thomas, R.C. George and J.G. Sutcliffe, Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders, Prostaglandins Leukot. Essent. Fatty Acids 69 (2003), 421-427.
101. T. Utsunomiya, K. Ogawa, K. Yoshinaga, M. Ohta, K. Yamashita, K. Mimori, H. Inoue, T. Ezaki, Y. Yoshikawa and M. Mori, Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma, Int. J. Cancer 116 (2005), 105-109.
102. S. Vijayaraghavan, G.A. Hitman and P.G. Kopelman, Apolipoprotein-D polymorphism: a genetic marker for obesity and hyperinsulinemia, J. Clin. Endocrinol. Metab. 79 (1994), 568-570.
103. D.X. Wen, Y.F. Xu, D.E. Mais, M.E. Goldman and D.P. McDonnell, The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells, Mol. Cell. Biol. 14 (1994), 8356-8364.
104. R.B. West, D.S. Nuyten, S. Subramanian, T.O. Nielsen, C.L. Corless, B.P. Rubin, K. Montgomery, S. Zhu, R. Patel, T. Hernandez-Boussard, J.R. Goldburn, P.O. Burn, M. van de Vijerand and M. van de Rijn, Determination of stromal signatures in breast carcinoma, PLoS Biol. 3 (2005), e187.
105. C.J. Witton, S.J. Hawe, T.G. Cooke and J.M. Bartlett, Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer, Histopathology 45 (2004), 47-54.
106. S. Xu and P. Venge, Lipocalins as biochemical markers of disease, Biochim. Biophys. Acta 1482 (2000), 298-307.
107. J.D. Yager and N.E. Davidson, Estrogen carcinogenesis in breast cancer, N. Engl. J. Med. 354 (2006), 270-282.
108. K. Yamashita, S. Upadhyay, M. Osada M, M.O. Hoque, Y. Xiao, M. Mori, F. Sato, S.J. Meltzer and D. Sidransky, Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma, Cancer Cell 2 (2002), 485-495.
109. J.K. Yao, E.A. Thomas, R.D. Reddy and M.S. Keshavan, Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia, Schizophr. Res. 72 (2005), 259-266.
110. S.X. Zhang, J.M. Bentel, C. Ricciardelli, D.J. Horsfall, D.E. Haagensen, V.R. Marshall and W.D. Tilley, Immunolocalization of apolipoprotein D, androgen receptor and prostate specific antigen in early stage prostate cancers, J. Urol. 159 (1998), 548-554.